Amerisourcebergen Corp
F:ABG
Amerisourcebergen Corp?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
196.78
274.5
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
What unique competitive advantages
does Amerisourcebergen Corp hold over its rivals?
What risks and challenges
does Amerisourcebergen Corp face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Amerisourcebergen Corp.
Provide an overview of the primary business activities
of Amerisourcebergen Corp.
What unique competitive advantages
does Amerisourcebergen Corp hold over its rivals?
What risks and challenges
does Amerisourcebergen Corp face in the near future?
Has there been any significant insider trading activity
in Amerisourcebergen Corp recently?
Summarize the latest earnings call
of Amerisourcebergen Corp.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Amerisourcebergen Corp.
Provide P/S
for Amerisourcebergen Corp.
Provide P/E
for Amerisourcebergen Corp.
Provide P/OCF
for Amerisourcebergen Corp.
Provide P/FCFE
for Amerisourcebergen Corp.
Provide P/B
for Amerisourcebergen Corp.
Provide EV/S
for Amerisourcebergen Corp.
Provide EV/GP
for Amerisourcebergen Corp.
Provide EV/EBITDA
for Amerisourcebergen Corp.
Provide EV/EBIT
for Amerisourcebergen Corp.
Provide EV/OCF
for Amerisourcebergen Corp.
Provide EV/FCFF
for Amerisourcebergen Corp.
Provide EV/IC
for Amerisourcebergen Corp.
Show me price targets
for Amerisourcebergen Corp made by professional analysts.
What are the Revenue projections
for Amerisourcebergen Corp?
How accurate were the past Revenue estimates
for Amerisourcebergen Corp?
What are the Net Income projections
for Amerisourcebergen Corp?
How accurate were the past Net Income estimates
for Amerisourcebergen Corp?
What are the EPS projections
for Amerisourcebergen Corp?
How accurate were the past EPS estimates
for Amerisourcebergen Corp?
What are the EBIT projections
for Amerisourcebergen Corp?
How accurate were the past EBIT estimates
for Amerisourcebergen Corp?
Compare the revenue forecasts
for Amerisourcebergen Corp with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Amerisourcebergen Corp and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Amerisourcebergen Corp against its competitors.
Analyze the profit margins
(gross, operating, and net) of Amerisourcebergen Corp compared to its peers.
Compare the P/E ratios
of Amerisourcebergen Corp against its peers.
Discuss the investment returns and shareholder value creation
comparing Amerisourcebergen Corp with its peers.
Analyze the financial leverage
of Amerisourcebergen Corp compared to its main competitors.
Show all profitability ratios
for Amerisourcebergen Corp.
Provide ROE
for Amerisourcebergen Corp.
Provide ROA
for Amerisourcebergen Corp.
Provide ROIC
for Amerisourcebergen Corp.
Provide ROCE
for Amerisourcebergen Corp.
Provide Gross Margin
for Amerisourcebergen Corp.
Provide Operating Margin
for Amerisourcebergen Corp.
Provide Net Margin
for Amerisourcebergen Corp.
Provide FCF Margin
for Amerisourcebergen Corp.
Show all solvency ratios
for Amerisourcebergen Corp.
Provide D/E Ratio
for Amerisourcebergen Corp.
Provide D/A Ratio
for Amerisourcebergen Corp.
Provide Interest Coverage Ratio
for Amerisourcebergen Corp.
Provide Altman Z-Score Ratio
for Amerisourcebergen Corp.
Provide Quick Ratio
for Amerisourcebergen Corp.
Provide Current Ratio
for Amerisourcebergen Corp.
Provide Cash Ratio
for Amerisourcebergen Corp.
What is the historical Revenue growth
over the last 5 years for Amerisourcebergen Corp?
What is the historical Net Income growth
over the last 5 years for Amerisourcebergen Corp?
What is the current Free Cash Flow
of Amerisourcebergen Corp?
Discuss the annual earnings per share (EPS)
trend over the past five years for Amerisourcebergen Corp.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
US |
A
|
Amerisourcebergen Corp
F:ABG
|
56.8B EUR | 14.4 | |
US |
![]() |
Mckesson Corp
NYSE:MCK
|
89.5B USD | 17.4 |
|
US |
![]() |
Cencora Inc
NYSE:COR
|
56.7B USD | 14.4 |
|
US |
![]() |
Cardinal Health Inc
NYSE:CAH
|
36.5B USD | 12.7 |
|
AU |
![]() |
Sigma Healthcare Ltd
ASX:SIG
|
36.1B AUD | 1 673.3 |
|
CN |
![]() |
Huadong Medicine Co Ltd
SZSE:000963
|
76.1B CNY | 16.8 |
|
CN |
![]() |
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
67.8B CNY | 10.4 |
|
KR |
![]() |
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 59.9 |
|
US |
![]() |
Henry Schein Inc
NASDAQ:HSIC
|
8.8B USD | 10.7 |
|
AU |
E
|
EBOS Group Ltd
OTC:EBOSY
|
8.2B USD | 30.5 |
|
CN |
![]() |
Sinopharm Group Co Ltd
HKEX:1099
|
57.7B HKD | 0.5 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
US |
A
|
Amerisourcebergen Corp
F:ABG
|
Average EV/EBITDA:
169.2
14.4
|
10%
|
1.4 | |
US |
![]() |
Mckesson Corp
NYSE:MCK
|
17.4
|
15%
|
1.2 |
|
US |
![]() |
Cencora Inc
NYSE:COR
|
14.4
|
10%
|
1.4 |
|
US |
![]() |
Cardinal Health Inc
NYSE:CAH
|
12.7
|
11%
|
1.2 |
|
AU |
![]() |
Sigma Healthcare Ltd
ASX:SIG
|
1 673.3
|
303%
|
5.5 |
|
CN |
![]() |
Huadong Medicine Co Ltd
SZSE:000963
|
16.8
|
18%
|
0.9 |
|
CN |
![]() |
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
10.4
|
17%
|
0.6 |
|
KR |
![]() |
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
59.9
|
32%
|
1.9 |
|
US |
![]() |
Henry Schein Inc
NASDAQ:HSIC
|
10.7
|
6%
|
1.8 |
|
AU |
E
|
EBOS Group Ltd
OTC:EBOSY
|
30.5
|
14%
|
2.2 |
|
CN |
![]() |
Sinopharm Group Co Ltd
HKEX:1099
|
0.5
|
2%
|
0.2 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.